Morgan Stanley on Wednesday began its coverage of hearing care company Amplifon (AMP.MI) with an overweight rating and a price target of 14.90 euros.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)